‘Trolls World Tour’ | Anatomy of a Scene – The New York Times

Hi, Im Walt Dohrn. Im the director of Trolls World Tour. First things first, these trolls need some serious cheering up, and were going to have to go top shelf. Now this scene here we find where Poppy, the queen of the Pop Trolls, is trying to connect with the Country Music Trolls by singing the most important songs of all time. So we had a lot of fun coming up with this scene. It started with hours and hours of meetings, making lists of guilty pleasures or songs so bad theyre good kind of idea, really recognizable songs. We really wanted to go over the top because from the Country Music Trolls point of view, these characters dont really understand the cultural sensitivity of this genre just yet. When we presented this notion to Anna Kendrick, who did the voice of Poppy, and Justin Timberlake, who is also our executive music producer, they rolled their eyes a little bit at the concept of this. But by the end of it, like these characters, they were completely into these songs. We had a choreographer who really choreographed this guy. And so the story artist add a lot of jokes, the choreographers add jokes, and then we take it to layout, who add some moments. And then it gets to the animators, who kind of interpret all of that business there. But one of the best jokes, I think, coming up, this kind of final joke. Tell em, Poppy. Shake that! [WIND WHISTLING] You suck! This you suck tumbleweed came out of an idea from a story artist, which I thought was really kind of perfectly described how most of the audience was feeling at this point. And this last joke here, Branch kind of has the last word. This was an improv from Justin. I think thats how he really felt. Well, I knew it. Who Let the Dogs Out, too far.

Read more:
'Trolls World Tour' | Anatomy of a Scene - The New York Times

‘Grey’s Anatomy Fans Are so Emotional About This Callback to George OMalley in the Season Finale – GoodHousekeeping.com

Leave it to Grey's Anatomy to make fans shed tears even with an unplanned early finale! The ABC medical drama aired its season 16 finale episode Thursday after cutting the season short due to the coronavirus crisis and amid all the rollercoaster moments of the episode, fans couldn't help but notice a subtle callback moment to none other than an old fan-favorite character, the late George O'Malley (yes, you read that right!).

The episode, titled "Put on a Happy Face," featured plenty of surprises, including (spoiler alert!) an official diagnosis for Richard Webber and an unexpected twist in the Owen-Teddy-Tom love triangle. But the highlight of the finale definitely came when Amelia Shepherd went into labor to deliver a healthy baby boy but since her boyfriend and baby daddy Link was in surgery, it was up to Miranda Bailey (Chandra Wilson) to help her out with the delivery. In a sweet callback to an old Grey's scene, Miranda then stepped in to sit behind Amelia during the delivery yes, exactly in the same way that George O'Malley (T.R. Knight) had done for Miranda way back in season 2!

Needless to say, Grey's fans couldn't help but tear up over the sweet and unexpected throwback moment to an old fan-favorite character, with many viewers taking to Twitter to express their emotional reactions over the sentimental scene.

"Okay JUST realized that Bailey helped Amelia through labor the SAME WAY George helped Bailey through labor," one fan wrote above a side-by-side photo of the two scenes. "Bailey climbing up on the table with Amelia sure was a callback to her labor with George ... and I am crying," another viewer tweeted, before adding a crying face emoji.

As longtime fans might remember, George O'Malley was among the many Grey's characters who have been killed off from the show, with actor T.R. Knight exiting the medical drama in 2009 due to a "breakdown of communication" with show creator Shonda Rhimes. Before George passed away in the first episode of season 6, however, the sweet moment in which he helped his mentor Miranda Bailey through her delivery was definitely one of the most memorable scenes in season 2 with Miranda even naming her son, William George Bailey Jones (known as "Tuck"), after him!

Of course, with such emotional moments in the season 16 finale, fans are now left wondering what's in store for the next season of Grey's Anatomy. Commenting on what's to come for season 17 of the show, Grey's showrunner Krista Vernoff made sure to tease that the writers are already brainstorming lots for the next upcoming episodes.

"I have a feeling that their stories are going to change some, from what we had planned, and that well repurpose some of what we had written and use it in the early episodes of Season 17," she said in an interview with Deadline.

Well, while we count the days until the next episode of Grey's, I guess we still have a lot to recover from especially with that sweet George O'Malley throwback, which we'll definitely be crying over for at least the next few weeks (if not months)!

View post:
'Grey's Anatomy Fans Are so Emotional About This Callback to George OMalley in the Season Finale - GoodHousekeeping.com

X-Men Anatomy: The 5 Weirdest Things About Emma Frost’s Body, Explained – CBR – Comic Book Resources

Since the X-Men's introduction to the Marvel Universe, mutants -- also known as homo superior -- have been discriminated against because their genetics make them anatomically different from non-mutants. Each homo superior's mutation variesand some mutants take on second mutations later in life. Emma Frost'sphysiology is one of the most impressive, with her mutation affecting both her body and mind.

Here are the five weirdest things about Emma Frost's body, explained.

RELATED: Emma Frost & Jean Grey Would Be the Ultimate Power Couple

Emma first debuted mid-Dark Phoenix Saga inUncanny X-Men #129, written by Chris Claremont with art by John Byrne. Her introduction established her as a huge threat to the X-Men because she was able to telepathicallytake out Colossus, Storm and Wolverine in one go. As an Omega Level telepath,her powers can reach a global scale.

Her abilities include broadcasting thoughts, mind control, psionic blasts, astral projections, mind reading and much more. She's used these telepathic abilities foracts of torture -- like in Astonishing X-Menwhen she implantedatrigger word (parsley) into an enemy's mind that would force him to vomit for 48 hours straight whenever he heard it -- as well as acts of peace, like when she ended a hate rally by placing the protesters' minds in a state of euphoria.

RELATED: X-Men: Does Krakoa Fit Into Marvel's 2099 Future?

There are two ways Emma can alter her body and one of those is by transposing her mind into someone else's head. Early on in her comichistory, Emma was able to use her psychic abilities to swap bodies with Storm in Uncanny X-Men#152. While Storm eventually broke free, this power makes Emma an incredibly dangerous mutant.

The other way she can alter her body is through mental projections. As seen in X-Men: First Class, Emma can make others see and feel something or someone who isn't there, including herself. Along with creatingbelievable projections of herself, she can also alter how people see her body as well as the bodies of others around her.

RELATED: X-Men May Be Marvel's Latest 'Secret Invasion' - But WAY More Horrifying

In writer Grant Morrison and artist Frank Quitely'sNew X-Men #114, the concept of a second mutation is introduced. Severalmutants who have this secondaryabilityinclude Iceman, Gambit, Jean Grey, Archangel and Emma. While some mutants can pass for human prior to taking on a second mutation,new powers can alter how they look entirely.

Where Iceman can alter his physical form to be made of ice, Emma can change her body to be made of organic diamond. In this form, every inch of her crystalizes and has the physical benefits of the gem stone. It also grants her a few bonus strengths, which furtherenhance her body and mind.

Related:X-Men: The Next Generation of X-Villains Is Here

Outside of her diamond form, Emma's physical body is similar to that of a non-mutant's, aside from the obvious X-Gene on her 23rd chromosome. However, in her diamond form,her body changes and affects her physicality entirely.

Diamonds are some of the strongest organicmaterials on Earth, so having a body made ofthis gem makes Emma incredibly durable and hard to damage. Along with being harder to injure, her new form grants Emma increased stamina and strength,allowing her to lift up two tons according to1000 Facts About Comic Book Characters Vol. 3by James Egan.

Related:X-Men: How House of M's Hero DESTROYED Marvel's Mutant Future

Along with physical benefits, Emma's diamond form grants her mental protections as well. X-Men: First Classstates that in her diamond form, Emma can resist telepathic attacks, even from Professor X -- another Omega Level mutant.

This wasn't always the case, though. In Morrison and artist Phil Jimenez'sNew X-Men #139, Jean Grey confronts Emma abouther affair with Scott Summers, digging through Emma's head and exposing some of her guiltiest memories, including the deaths of her students andher love for Scott. Jean does such a number on her that Emma shatters into diamond pieces.

These aspects of Emma's body make her one of strongest mutants physically and mentally. Whether she is on the side of good, evil or somewhere in between, her mutations as well as her natural talent and brilliant mind make her one of Marvel's stand out femme fatales.

KEEP READING: X-Men and Star Trek: Picard Are Setting Up the Same Endgame

Justice League Anatomy: The 5 Weirdest Things About Hawkman's Body

After moving to New York, Caitlin Sinclair Chappell got a job at Forbidden Planet, a science fiction and comic book mega store, working as a sales associate and a writer for their newsletter, the Weekly Planet. Prior to moving across country, Caitlin was a honors student at Lewis & Clark College, where she was an editorial intern at Dark Horse Comics, a director on several short films, and a writer for the Odyssey and the Piolog - her articles focusing on comics, film, and theatre. With several friends from Portland, Caitlin co-started the Comic Book Buds podcast, which she still co-hosts to this day. In her free time, Caitlin volunteers for festivals and conventions like NewFest, Screamfest, and Wizard World. Shes currently working on a handful of creative projects, including her first comic and a two act play.

The rest is here:
X-Men Anatomy: The 5 Weirdest Things About Emma Frost's Body, Explained - CBR - Comic Book Resources

Grey’s Anatomy season 16: Was Dr Alex Karev going to be killed off in Grey’s Anatomy? – Express

Grey's Anatomy aired its final episode of season 16 called Put On A Happy Face on ABC on Thursday, April 9. The medical drama was meant to have a few more episodes left but as filming could no longer take place, the makers of Grey's Anatomy had to make episode 21 the last one. But fans shouldn't be worried about the show's future as Grey's Anatomy has already been renewed for a 17th season.

WARNING: This article contains spoilers from Grey's Anatomy season 16,

Actor Justin Chambers who has played Dr Alex Karev since Grey's Anatomy first began 15 years ago, announced in 2019 that he would be leaving the show for good.In a statement, he said: Theres no good time to say goodbye to a show and character thats defined so much of my life for the past 15 years.For some time now, however, I have hoped to diversify my acting roles and career choices."And, as I turn 50 and am blessed with my remarkable, supportive wife and five wonderful children, now is that time.The big question which remained following the news was how he was going to leave the series.

READ MORE:Greys Anatomy season 17 release date: Will there be another series?

Chambers' last ever episode was actually shown back in November and sadly for fans, he did not appear again.Many questioned where he had gone but in episode 16 Leave A Light On, things made a lot clearer.His wife Jo Wilson (Camilla Luddington) had already told colleagues her and Alex's marriage was over but no real explanation was given as to why.He had told everyone he was going to visit his sick mother but the real reason for his exit was far more shocking.

After Dr Meredith Grey (Ellen Pompeo) got in trouble for insurance fraud, Alex thought this was a good excuse to get back in touch with his ex-wife Dr Izzie Stevens (Katherine Heig), who left Grey Sloan Memorial Hospital in season six.When Izzie and Alex were still together and she had Stage IV cancer, she froze her embryos just in case she could no longer have children naturally.So when she left the series, Izzie used the embryos to have her and Alex's twins who were now five-years-old.He didn't have any knowledge of this but when he found out, he wrote several letters, including to Jo and Meredith, explaining what had happened and how he had decided he would stay with Izzie and the children on a farm in Kansas.Since the episode aired, showrunner Kirsta Vernoff has opened up about writing Alex out of the series and if there was ever a chance of Alex being killed off.

DON'T MISS...Grey's Anatomy season 17: Will Jackson Avery leave for Station 19?[CAST]Grey's Anatomy spin-off: Will there be another spin-off show?[EXPLAINER]Greys Anatomy season 16 spoilers: Will Richard Webber die?[SPOILER]

Speaking to TVLine, Vernoff confirmed there was never any intention to have Alex killed off.She said: "At the end of the day, there were three choices.Kill Alex off camera; have Alex be alive and in Seattle and still married to Jo and we just never see him; or [reunite him] with Izzie.Vernoff insisted killing Alex would have been cruel to everyone particularly Meredith and Jo".She continued: There was no way to not put those characters through gut-wrenching, ongoing grief if we had killed Alex off camera.Some fans were upset, particularly the Jolex shippers, that [Alex left Jo to be with Izzie] and I understand why.

"But I would fight real hard anyone who tried to tell me that fans would not have been equally or more upset if I had killed Alex Karev off camera.Vernoff also added how there wasn't "even a debate in the writers' room" about reuniting him with Izzie off-screen when the idea was brought up.But fans will just have to wait and see if either Alex and or Izzie will ever make another appearance in Grey's Anatomy in the future.Grey's Anatomy season 16 is available to watch on ABC.

Follow this link:
Grey's Anatomy season 16: Was Dr Alex Karev going to be killed off in Grey's Anatomy? - Express

My Gene Counsel Partners with UConn Health to Provide Expanded Genetic Counseling Services – Yahoo Finance

Easy-to-understand genetic counseling reports will lead to more appropriate follow-up and better health outcomes

NEW HAVEN, Conn., April 16, 2020 /PRNewswire-PRWeb/ -- My Gene Counsel, a digital health company that provides innovative genetic counseling solutions, today announced it is teaming up with UConn Health's Neag Comprehensive Cancer Center's Hereditary Cancer Program to ensure that UConn's patients who have undergone genetic testing for cancer predisposition have access to timely and accurate genetic counseling information through the online delivery of My Gene Counsel's Living Lab Reports. Together, My Gene Counsel and UConn Health will use state-of-the-art digital tools to efficiently communicate up-to-date genomic information that will drive an improved standard of care.

By supplementing its current genetic counseling services with My Gene Counsel's digital counseling tools, UConn Health will serve as a leader in this space with the ability to better support patients over time in the post-test period. Each incoming patient will receive an electronic Living Lab Report sponsored by UConn Health and the Linda Clemens Breast Cancer Foundation that is personalized to the individual's genetic test results and outlines the most frequently asked questions and answers on topics related to disease risk, medical management options, relevance to family, emotional support, and available resources. This information is supported by tools to enhance understanding, such as hover dictionary and graphics.

"Genetics can be overwhelming and confusing, so when a patient leaves my office, I worry about how much information they have retained," said Connor Linehan, MS, LGC, a board-certified genetic counselor for the Hereditary Cancer Program at UConn Health. "Our goal, in partnering with My Gene Counsel, is to increase patient understanding in the hopes that better comprehension equals appropriate medical follow-up and better health outcomes. The addition of a user-friendly genetic counseling report that patients can review before and after their appointment and over time will be invaluable to empower them to make informed decisions about their healthcare."

The Living Lab Reports are written and continuously updated by a network of top certified genetic counselors and medical experts and are vetted by patient advocates. In addition to delivering complex genomic information in a way that patients can understand, the reports will update and notify patients automatically by text and/or email as My Gene Counsel adds new information to reflect changes in disease risk, medical management options, variant reclassification, and relevant clinical trials.

"I encourage patients to contact us over the years as information about hereditary cancer changes over time," said Jennifer Stroop, MS, CGC, LGC, a board-certified genetic counselor for the Hereditary Cancer Program at UConn Health. "However, this is not always easy. We are very excited to now be able to offer our patients a reference tool with continuing updates and notifications. With these continued touchpoints for engagement and retention, we will be able to meet the expressed need to help our patients feel more connected and supported in the long term."

My Gene Counsel's wraparound solution, available at UConn in May 2020, will enable the responsible return of results, engage and update patients, and integrate data into UConn's health care system. Living Lab Reports will be personalized by gene and variant and provided for all results, whether testing is negative or identifies a variant of clinical or uncertain significance.

"We are excited to partner with UConn Health, a forward-thinking health system on the cutting-edge of hereditary cancer and precision medicine," said Ellen Matloff, MS, CGC, president and CEO of My Gene Counsel. "Their dedication to improving health through education, innovation, and patient-centered clinical care beyond the initial genetic test aligns seamlessly with our own ideals."

More than 600 people undergo genetic counseling and testing each year as part of the Neag Comprehensive Cancer Center's Hereditary Cancer Program, which is staffed by two genetic counselors. The expanding volume of patients and limited bandwidth led the team to proactively seek out a technical solution that could help solve the challenge of monitoring critical clinical updates and research and recontacting patients.

Story continues

"It is essential for UConn Health, as a major university center, to keep pace with the growing demand for up-to-date genomic information," said Susan Tanenbaum, MD, medical director of the Neag Comprehensive Cancer Center. "The integration with My Gene Counsel is a giant step towards UConn Health assuming a position of global leadership in genomics and personalized medicine."

About My Gene Counsel: My Gene Counsel bridges the gap between genetic testing and precision medicine by addressing one of the most critical pain points in the industry lack of accurate and timely genetic counseling information for patients and providers. Their Living Lab Reports deliver genetic counseling information that updates as new clinical information emerges, guidelines evolve, and genetic variants are reclassified. Founded by certified genetic counselors with 30+ years of clinical experience, My Gene Counsel empowers partners to efficiently deliver on the promise of precision medicine. For more information, visit http://www.mygenecounsel.com.

About UConn Health: UConn Health is Connecticut's only public academic medical center. Based on a 206-acre campus in Farmington, UConn Health has a three-part mission: research, teaching and patient care. Home to the UConn School of Medicine, School of Dental Medicine and UConn John Dempsey Hospital with nearly 5,000 employees supporting nearly 1,000 students, over 800,000 annual patient visits, and innovative scientific research contributing to the advancement of medicine. For more information, visit http://www.health.uconn.edu.

SOURCE My Gene Counsel

Continue reading here:
My Gene Counsel Partners with UConn Health to Provide Expanded Genetic Counseling Services - Yahoo Finance

Video: The evolution, genetics and virulence of coronaviruses – Genetic Literacy Project

It is easier than ever for advocacy groups to spread disinformation on pressing science issues, such as the ongoing coronavirus pandemic. No, vaccines are not harmful. Yes, the use of biotechnology, GMOs or gene editing to develop antigens for treatments including vaccines are part of the solution. To inform the public about whats really going on, we present the facts and challenge those who don't. We cant do this work without your help. Please support us a donation of as little as $10 a month helps support our vital myth-busting efforts.

More here:
Video: The evolution, genetics and virulence of coronaviruses - Genetic Literacy Project

One in a million: Rare genetic disorder means this toddler smiles with her eyes – TheChronicleHerald.ca

This week, we're profiling five very special Maritime families who have children with rare genetic disorders. This is the fourth article.Read more about the series by Lifestyles editor Jen Taplinhere

Ivy Stewart cant move her face, but she smiles with her eyes.

The adorable blond, wispy-haired two-year-old has big blue eyes, pink toddler cheeks and a tiny little mouth. She also has Moebius syndrome, which means theres no movement in the muscles in her face.

She doesnt blink. Instead, her eyes roll up and back every few minutes.

She loves everything, says her mom, Emily.

Even with not having expression, she finds other ways to express herself. With Moebius syndrome they say smile with your heart, and we say she smiles with her heart or her eyes.

Its a busy morning at Ronald McDonald House in Halifax as the Stewart family Emily, Craig and their three kids: Olive, 5; Ivy, 2; and Levi, 11 months preparesfor the long drive back to their hometown of Woodstock, N.B.

Ivy is sitting in a high chair, draining a package of apple sauce while her baby brother cuddles mom and big sister attacks a colouring page.

Its a five-hour drive but a 45-minute air ambulance ride from their home to the IWK Health Centre in Halifax. They should know, theyve had to take Ivy by air ambulance three times in her short life.

One airlift when she was little, they had to do an IV from her head because her veins were so small. They had to poke her quite a few times because her veins kept blowing, said Emily.

Airlifts are always emotional, she adds.

The last one was in January because of a breathing problem. Ivy has small airways and a respiratory infection can turn dangerous fast. They were back in Halifax in February for a tonsillectomy so that the next time she has swelling in her throat, there will be more room.

Making the trip to Halifax is something theyve grown used to since their second child was born. It was at the 20-week ultrasound when their doctor in New Brunswick told them their baby had club feet, was very small and had a lemon-shaped skull.

Ivy didnt cry when she was born. She wasnt breathing much either because she couldnt open her mouth.

Emily and Craig didnt have the time to process the situation in those first few days.

It was Day 4 and I got discharged (from the hospital) but she was still in, says Emily.

Someone came behind me with their baby and I just remember that moment I broke down and cried because that was the moment we realized we were leaving without our baby.

For Craig, that breakdown came after weeks of daily hospital visits.

Thats when I was able to comprehend everything and get it through my brain, he says.

As their baby grew, they noticed when she cried there was no expression on her face. When Ivy was two months old, they had an appointment with the genetics clinic, where they started the process of testing and waiting months for the results to come back.

Then at six months she got respiratory syncytial virus, a serious respiratory illness.

She was in the hospital in Fredericton, struggling to breathe while having undiagnosed seizures. She was airlifted to the IWK, where she saw specialists who ended up diagnosing Ivy with Moebius syndrome, a rare genetic disorder.

To see the little blessings in things like that is how we have to take it with ourselves. Even though its an emotional experience to look back on it, the blessing from it is we came out with all the new doctors that she needed, Emily said.

It was just a relief, that feeling to just have an answer. And then when we had an answer, we had a path to move ahead.

Having a diagnosis meant getting Ivy on seizure medications that made a big difference (she hasnt had a big seizure since July), and setting up a care regimen that involves eye drops once an hour and ointment three times a day. Shes eating now, but she was mostly fed through a gastrostomy tube until she was 18 months old.

Doctors at Toronto Sick Kids have developed a smile surgery for kids with Moebius when theyre four or five years old, and Ivy is considered a good candidate. Surgeons will take a muscle from her thigh and attach it to her jaw. Through physiotherapy, shell learn to activate it.

Until then, weve been showing her how to push her fingers up and make a smile, which is something we learned from other parents, Emily says.

Connecting with parents of children with Moebius syndrome or other rare genetic disorders makes a big difference.

Its huge because you dont know what to expect, and in general people can sympathize but they dont really understand the extent of everything, Craig says.

It was actually really nice to meet some other families and talk to other people that either had similar experiences or very close to being the same.

Adds Emily: Even if youre not going through the same thing, everyone can relate to the hospital life.

Read more about our series here.

Part One, The Gardiner family:Nature chose her. Toddler faces 40+ surgeries in her lifetimePart Two, The Langille family:Little Georgia has the rarest of disorders. We just do the best we can.Part Three, The Jacksons:I know my little girl is in there; Truro family lives with heartbreaking uncertainties

Go here to read the rest:
One in a million: Rare genetic disorder means this toddler smiles with her eyes - TheChronicleHerald.ca

Next-generation gene-editing technology: Path to a second Green Revolution? – Genetic Literacy Project

One of the major limitations of the first-generation rDNA-based GM methods is the randomness of DNA insertions into plant genomes, just as the earlier mutagenesis methods introduced mutations randomly. The newer methods increase the specificity and precision with which genetic changes can be made. Known under the general rubric of sequence-specific nuclease (SSN) technology or gene/genome-editing, this approach uses proteins or protein-nucleic acid complexes that bind to and cut specific DNA sequences.1 SSNs include transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and meganucleases.2

[This is part three of a four-part series on the progress of agricultural biotechnology. Read part one and part two.]

The DNA cuts made by SSNs are repaired by cellular processes that often either change one to several base pairs or introduce deletions and/or insertions (aka indels) at the target site. Another recently added technology capable of editing gene sequences is termed oligonucleotide-directed mutagenesis (ODM) and uses short nucleic acid sequences to target mutations to selected sites.3

The hottest and the coolest

What is rapidly emerging as the most powerful of the SSN technologies is known by the uninformative acronym CRISPR/Cas, which contracts the unwieldy designation clustered regularly interspaced short palindromic repeats (CRISPR)CRISPR-associated protein (Cas9). Its based on a bacterial defense system against invading viruses and promises extraordinary versatility in the kinds of genome changes that it can make.1,4

The CRISPR/Cas editing molecular machine is comprised of an enzyme (Cas9 and other variants) that binds an RNA molecule (called the guide RNA or gRNA) whose sequence guides the complex to the matching genomic sequence, allowing the Cas9 enzyme to introduce a double-strand break within the matching sequence. The CRISPR/Cas system can be used to edit gene sequences, to introduce a gene or genes at a pre-identified site in the genome, and to edit multiple genes simultaneously, none of which could be done with rDNA methods.1,5

Many of the genetic changes created using either SSN or ODM are indistinguishable at the molecular level from those that occur in nature or are produced by mutation breeding. Since both spontaneous mutants and chemical- and radiation-induced mutants have been used in crop improvement without regulation, there is no scientific rationale for regulating mutants produced by the newer methods. In hopes of creating a distinction that will permit exemption of gene-edited crops from regulation, the newer methods are increasingly referred to as new plant breeding techniques (NPBTs or just NBTs).

Quick successes for NBTs?

Prime targets of gene editing are cellular proteins that are involved in pathogenesis.6 Virus reproduction requires the recruitment of cellular proteins for replication, transcription and translation. There can be sufficient redundancy in the requisite protein infrastructure so that partial or complete virus resistance can be achieved by disrupting genes that code for proteins required for viral replication without damaging crop productivity.

For example, work with mutants of the model plant Arabidopsis identified translation initiation factor eIF4E as required for potyvirus translation. CRISPR/Cas-induced point mutations and deletions have recently been reported to enhance viral resistance not only in Arabidopsis, but in cucumber and cassava, as well.7

The many ways that plants and their bacterial and fungal pathogens interact offer opportunities to use gene editing to enhance plant disease resistance and reduce agricultures dependence on chemical control agents.6 The two main strategies are to inactivate genes whose products render the host plant sensitive to pathogen invasion and to enhance the ability of the host plant to resist invasion by providing functional resistance factors they lack.

An example of the former is provided by the mildew resistance resulting from the inactivation of all three homeoalleles of the mildew resistance locus (MLO) of hexaploid wheat.8 The efficiency of targeting both multiple alleles and multiple loci has taken a further jump with the development of multiplexed gene editing using vectors carrying several gRNA sequences capable of being processed by cellular enzymes to release all of them. This allows the gRNAs to edit multiple genes simultaneously.9

The second approach is to capitalize on the formidable arsenal of resistance genes residing in plant genomes.10 Fungal resistance genes have long been a major target of breeders efforts and have proved frustratingly short-lived, as pathogens rapidly evolve to evade recognition.11 While desirable resistance genes missing from domesticated crops still reside in wild relatives, extracting them by conventional breeding methods can be time-consuming or impossible.

European academic researchers created transgenic potatoes resistant to the late blight (Phytophthora infestans) that caused the Irish potato famine by inserting resistance (R) genes cloned from wild potato species into commercial potato varieties.12 A blight-resistant variety, called the Innate Generation 2 potato, is being commercialized by J.R. Simplot company in the U.S. and Canada and is already being marketed in the U.S. as the White Russet Idaho potato.13 Transgenic disease-resistance traits have been introduced in other crops, but have yet to be commercialized.14

Plant genomes contain hundreds to thousands of potential R genes, but it is not yet possible to determine whether a given one will confer resistance to a particular pathogen. Methods are currently being developed to accelerate the identification and cloning of active ones.14 Once identified, CRISPR/Cas can be used to introduce cassettes carrying multiple R genes, making it possible to create more durable resistance than can be achieved by introducing a single R gene through conventional breeding14. Finally, direct editing of resident inactive R genes using a ribonucleoprotein (RNP) strategy that avoids creating a transgenic plant may prove useful, although no such products appear to be in the pipeline to commercialization at present.15,16

Multiplexed editing has proved particularly useful for editing genes in polyploid species. For example, Cas9/sgRNA-mediated knockouts of the six fatty acid desaturase 2 (FAD2) genes of allohexaploid Camelina sativa was reported to markedly improve the fatty acid composition of Camelina oil.17 Using a different approach, Yield10 Biosciences is moving toward commercialization of a high-oil Camelina developed by editing a negative regulator of acetyl-CoA carboxylase.18

As of this writing, the only gene-edited product that has been commercialized is a soybean oil with no trans-fat, trademarked Calyno, developed by Calyxt.19 Gene-edited crops that have been approved but not commercialized or are still in the regulatory pipeline include miniature tomatoes, high-fiber wheat, high-yield tomatoes, improved quality alfalfa, non-browning potatoes and mushrooms, as well as high starch-content and drought-resistant corn, most being developed by small biotech companies.19

Getting beyond the low-hanging fruit

It is becoming increasingly clear that yield increases in our major crops by traditional breeding approaches are not keeping pace with demand.20 The gap is likely to widen as climate warming moves global temperatures farther from those prevailing when our crops were domesticated.

Overexpression of stress-related transcription factors has been reported to increase yields under water-stress conditions, but such increases are generally not maintained under optimal conditions.21 Monsantos drought-tolerant (Genuity DroughtGard) corn hybrids are based on the introduction of bacterial chaperone genes.22 Fortunately, research into drought stress tolerance in wheat and other grains continues apace, although no drought-tolerant varieties have yet reached farmers.23

Real progress on crop yield is slow. What stands in the way is that we have so limited an understanding of how plants work at the molecular level. At every level of analysis, organisms are redundant networks of interconnected proteins that adjust their manifold physical and enzymatic interactions in response to internal signals and external stimuli, then send messages to the information storage facilities (DNA) to regulate their own production and destruction rates.

As well, many genes are present in families of between two and hundreds or thousands of similar members, making it difficult to determine either the function or the contribution of any given member to a complex trait such as stress tolerance or yield. That said, gene family functions are identifiable and some, such as transcription factor genes, encode proteins that influence multiple other genes, making them among the likeliest candidates for manipulation. Indeed, studies on the genetics of domestication often point to changes in transcription factor genes.24

But while there have been reports that constitutive overexpression of single transcription factor gene can increase grain yield in both wheat and maize, none appear to have been commercialized yet.25 The challenge of developing a yield-improved variety by simply overexpressing transcription factor genes is illustrated by a recent report from Corteva.26 It describes a tour-de-force involving generation and testing of countless transgenic plants to identify a single transcription factor gene, ZMM28, that reproducibly increased yield when incorporated into 48 different hybrids and tested over a 4-year period in 58 locations.26

Getting there by a different route

Might gene-editing facilitate the task of generating and identifying yield-enhancing genetic variation? While the CRISPR/Cas toolkit is growing at dizzying speed, its utility in crop improvement has so far been limited to the simple traits controlled by individual genes, albeit including multiple alleles.1,27

Crop domestication and plant breeding have vastly narrowed genetic diversity because the very process of selecting plants with enhanced traits imposes a bottleneck, assuring that only a fraction of the ancestral populations genetic diversity is represented in a new elite variety. This, in turn, limits what can be done by mutagenizing existing elite varieties, a process that is also burdened with the necessity to eliminate deleterious mutations through back-crossing.

But to widen the genetic base and to modify genes that contribute to quantitative traits, it is still first necessary to identify the genes that contribute to agronomically important traits. Identifying such genes is currently a slow and tedious process of conventional and molecular mapping.28 A recent report describes a method for combining pedigree analysis with targeted CRISPR/Cas-mediated knockouts that promises to markedly accelerate the identification of the individual contributing genes in the chromosomal regions that are associated with quantitative traits, technically known as quantitative trait loci (QTLs).29

Even as the QTL knowledge gap narrows, gRNA multiplexing is extending the power of SSNs to understanding and modifying complex traits in crop plants. For example, using multiplexed gRNAs, Cas nuclease was simultaneously targeted to three genes known to be negative regulators of grain weight in rice.30 The triple mutants were reported to exhibit increases in the neighborhood of 25% in each of the three grain weight traits: length, width and thousand grain weight.

In another study, 8 different genes affecting rice agronomic traits were targeted with a single multiplexed gRNA construct and all showed high mutation efficiencies in the first generation.31 Conversely, it has been reported that editing the same QTLs gives different outcomes in different elite varieties, improving yield in some but not other.32

Mutations affecting the expression of regulatory genes, such as transcription factors genes, account for a substantial fraction of the causative genetic changes during crop domestication.33 Multiplexed gRNAs constructs targeting cis-regulatory elements (CREs) have been used to generate large numbers of allelic variants of genes affecting fruit size in tomato, mimicking some of the mutations accumulated during domestication and breeding of contemporary tomato varieties.34

Knowledge of domestication genes can also be used to accelerate domestication of wild plants that retain traits of value, such as salt tolerance, as reported for tomato.35 This opens the possibility of rapidly domesticating wild species better adapted to the harsher climate conditions of the future.

While the above-described advances have been based on the CRISPR/Cas-mediated deletions, approaches to more precise sequence editing are developing as well. While Cas-generated cuts in the DNA are most commonly repaired by the non-homologous end joining pathway (NHEJ), the less frequent homology-directed repair pathway (HDR) has been shown to edit sequences at useful frequencies using Cas-gRNA ribonucleoprotein complexes.15,36

As well, mutant Cas9 proteins lacking nuclease activity have been fused with base-editing enzymes such as cytidine and adenosine deaminases to direct gene editing without DNA cleavage.37,38 This approach can change single base pairs precisely in both coding and non-coding regions, as well alter mRNA precursor processing sites.38 Finally, the sequence targeting properties of the CRISPR-Cas system can be used to deliver other types of hybrid proteins to target sequences to regulate gene expression and DNA methylation.27

In sum, the many variations on gene editing now developing hold the promise of revolutionizing crop breeding, prompting several colleagues to whimsically title a recent review of CRISPR/Cas-based methodology: Plant breeding at the speed of light.39 And indeed, the new methods make it possible to replace chemicals with biological mechanisms in protecting plants from pests and disease, as well as increase their resilience to stress.

That said, extraordinary progress in increasing grain yields has already been accomplished by what are now considered to be traditional breeding methods and increased fertilizer use. Further improvements continue, but will likely be harder won than the many-fold increases in corn, wheat and rice yields of the last century and its Green Revolution. But there is a persistent disconnect between what can be done to accelerate plant breeding using the new gene-editing toolkit and what is actually being done by both the public and private sectors to get varieties improved by these methods out to farmers.

1Zhang Y et al. (2019). The emerging and uncultivated potential of CRISPR technology in plant science. Nature Plants 5:778-94.

2Podevin N et al. (2013). Site-directed nucleases: a paradigm shift in predictable, knowledge-based plant breeding. Trends Biotechnol 31:375-83.

3Sauer NJ et al. (2016). Oligonucleotidedirected mutagenesis for precision gene editing. Plant Biotechnol J 14:496-502.

4Zhang D et al. (2016). Targeted gene manipulation in plants using the CRISPR/Cas technology. J Genet Genomics 43:251-62.

5Cong L et al. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-23.

6Borrelli VM et al. (2018). The enhancement of plant disease resistance using CRISPR/Cas9 technology. Frontiers Plant Sci 9:Article 1245.

7Chandrasekaran J et al. (2016). Development of broad virus resistance in nontransgenic cucumber using CRISPR/Cas9 technology. Molec Plant Pathol 17:1140-53; Pyott DE et al. (2016). Engineering of CRISPR/Cas9mediated potyvirus resistance in transgenefree Arabidopsis plants. Molec Plant Pathol 17:1276-88; Gomez MA et al. (2019). Simultaneous CRISPR/Cas9mediated editing of cassava eIF 4E isoforms nCBP1 and nCBP2 reduces cassava brown streak disease symptom severity and incidence. Plant Biotechnol J 17:421-34.

8Wang Y et al. (2014). Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew. Nature Biotechnol 32:947.

9Xie K et al. (2015). Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc Natl Acad Sci 112:3570-5; Wang W et al. (2018). Transgenerational CRISPR-Cas9 activity facilitates multiplex gene editing in allopolyploid wheat. The CRISPR J 1:65-74.

10Petit-Houdenot Y and Fudal I (2017). Complex interactions between fungal avirulence genes and their corresponding plant resistance genes and consequences for disease resistance management. Frontiers Plant Sci 8:1072.

11Bebber DP and Gurr S (2015). Crop-destroying fungal and oomycete pathogens challenge food security. Fungal Genet Biol 74:62-4; van Esse HP et al. (2020). Genetic modification to improve disease resistance in crops. New Phytol 225:70-86.

12Jones JD et al. (2014). Elevating crop disease resistance with cloned genes. Phil Trans Royal Soc B: Biol Sci 369:20130087; Haesaert G et al. (2015). Transformation of the potato variety Desiree with single or multiple resistance genes increases resistance to late blight under field conditions. Crop Protection 77:163-75.

13Halsall M. Innate outlook. Spudsmart, 24 April 2019 https://spudsmart.com/innate-outlook/

14Dong OX and Ronald PC (2019). Genetic engineering for disease resistance in plants: recent progress and future perspectives. Plant Physiol 180:26-38.

15Svitashev S et al. (2016). Genome editing in maize directed by CRISPRCas9 ribonucleoprotein complexes. Nature Communications 7:1-7.

16Mao Y et al. (2019). Gene editing in plants: progress and challenges. Nat Sci Rev 6:421-37.

17Morineau C et al. (2017). Selective gene dosage by CRISPRCas9 genome editing in hexaploid Camelina sativa. Plant Biotechnol J 15:729-39; Jiang WZ et al. (2017). Significant enhancement of fatty acid composition in seeds of the allohexaploid, Camelina sativa, using CRISPR/Cas9 gene editing. Plant Biotechnol J 15:648-57.

18Yield10 Bioscience (Jan 16, 2020 ). Yield10 Bioscience submits Am I Regulated? letter to USDA-APHIS BRS for CRISPR genome-edited C3007 in Camelina to pave the way for U.S. field tests. https://www.globenewswire.com/news-release/2020/01/16/1971418/0/en/Yield10-Bioscience-Submits-Am-I-Regulated-Letter-to-USDA-APHIS-BRS-for-CRISPR-Genome-Edited-C3007-in-Camelina-to-Pave-the-Way-for-U-S-Field-Tests.html

19Genetic Literacy Project (2020). Global Gene Editing Regulation Tracker. https://crispr-gene-editing-regs-tracker.geneticliteracyproject.org/united-states-crops-food/

20Ray DK et al. (2013). Yield trends are insufficient to double global crop production by 2050. PloS One 8:e66428.

21Rice EA et al. (2014). Expression of a truncated ATHB17 protein in maize increases ear weight at silking. PLoS One 9:e94238; Araus JL et al. (2019). Transgenic solutions to increase yield and stability in wheat: shining hope or flash in the pan? J Experimental Bot 70:1419-24.

22Castiglioni P et al. (2008). Bacterial RNA chaperones confer abiotic stress tolerance in plants and improved grain yield in maize under water-limited conditions. Plant Physiol 147:446-55.

23Mwadzingeni L et al. (2016). Breeding wheat for drought tolerance: Progress and technologies. J Integrative Agricult 15:935-43; Sallam A et al. (2019). Drought stress tolerance in wheat and barley: Advances in physiology, breeding and genetics research. Internat J Mol Sci 20:3137.

24Swinnen G et al. (2016). Lessons from domestication: targeting cis-regulatory elements for crop improvement. Trends Plant Sci 21:506-15.

25Nelson DE et al. (2007). Plant nuclear factor Y (NF-Y) B subunits confer drought tolerance and lead to improved corn yields on water-limited acres. Proc Natl Acad Sci 104:16450-5; Qu B et al. (2015). A wheat CCAAT box-binding transcription factor increases the grain yield of wheat with less fertilizer input. Plant Physiol 167:411-23; Yadav D et al. (2015). Constitutive overexpression of the TaNF-YB4 gene in transgenic wheat significantly improves grain yield. J Experiment Bot 66:6635-50.

26Wu J et al. (2019). Overexpression of zmm28 increases maize grain yield in the field. Proc Natl Acad Sci 116:23850-8.

27Chen K et al. (2019). CRISPR/Cas genome editing and precision plant breeding in agriculture. Annu Rev Plant Biol 70:667-97.

28Cavanagh C et al. (2008). From mutations to MAGIC: resources for gene discovery, validation and delivery in crop plants. Curr Opin Plant Biol 11:215-21.

29Huang J et al. (2018). Identifying a large number of high-yield genes in rice by pedigree analysis, whole-genome sequencing, and CRISPR-Cas9 gene knockout. Proc Natl Acad Sci 115:E7559-E67.

30Xu R et al. (2016). Rapid improvement of grain weight via highly efficient CRISPR/Cas9-mediated multiplex genome editing in rice. J Genet Genom 43:529.

31Shen L et al. (2017). Rapid generation of genetic diversity by multiplex CRISPR/Cas9 genome editing in rice. China Sci Life Sci 60:506-15.

32Shen L et al. (2018). QTL editing confers opposing yield performance in different rice varieties. J Integrative Plant Biol 60:89-93; Zhou J et al. (2019). Multiplex QTL editing of grain-related genes improves yield in elite rice varieties. Plant Cell Rep 38:475-85.

33Meyer RS and Purugganan MD (2013). Evolution of crop species: genetics of domestication and diversification. Nature Rev Genet 14:840-52.

34Rodrguez-Leal D et al. (2017). Engineering quantitative trait variation for crop improvement by genome editing. Cell 171:470-80. e8.

35Li T et al. (2018). Domestication of wild tomato is accelerated by genome editing. Nature Biotechnol 36:1160-3; Zsgn A et al. (2018). De novo domestication of wild tomato using genome editing. Nature Biotechnol 36:1211-6.

36Puchta H et al. (1996). Two different but related mechanisms are used in plants for the repair of genomic double-strand breaks by homologous recombination. Proc Natl Acad Sci 93:5055-60; Zhang Y et al. (2016). Efficient and transgene-free genome editing in wheat through transient expression of CRISPR/Cas9 DNA or RNA. Nature Communications 7:1-8.

37Komor AC et al. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420-4; Hua K et al. (2019). Expanding the base editing scope in rice by using Cas9 variants. Plant Biotechnol J 17:499-504.

38Kang B-C et al. (2018). Precision genome engineering through adenine base editing in plants. Nature Plants 4:427-31.

39Wolter F et al. (2019). Plant breeding at the speed of light: the power of CRISPR/Cas to generate directed genetic diversity at multiple sites. BMC Plant Biol 19:176.

Nina V. Fedoroff is an Emeritus Evan Pugh Professor at Penn State University

More:
Next-generation gene-editing technology: Path to a second Green Revolution? - Genetic Literacy Project

PAI Life Sciences Biochemistry Expertise Links with Hemex Healths Gazelle Miniaturized Rapid Diagnostic Platform to Develop Pandemic Test – Yahoo…

Two Pacific Northwest Companies Partner to Develop Affordable COVID-19 Six Minute Diagnostic Test for Use in Low Resourced Countries

SEATTLE and PORTLAND, Ore., April 15, 2020 (GLOBE NEWSWIRE) -- Researchers in Seattle and Portland have agreed to collaborate on an urgently needed rapid COVID-19 diagnostic test that can diagnose patients accurately, quickly, and inexpensively, anywhere in the world. The platform behind the rapid COVID-19 test is designed to work in low resourced locations from Mumbai to Mogadishu, and remote villages in between. Researchers expect to have the device ready for a clinical study within a few months.

Once developed and necessary approvals are obtained, the affordable technology will be used for early detection of cases of COVID-19 to help health workers stop the spread of the disease on short notice.

The COVID-19 diagnostic uses Portland-based Hemex Healths Gazelle Diagnostic platform that combines known and trusted testing with cloud-based reporting, in a reader smaller than a shoebox, battery powered, and chargeable with a cell phone charger.Gazelle combines miniaturized electrophoresis with automation and a video interface for rapid, easy, and consistent reading. Significantly, Gazelle eliminates the need for cold-chain necessary with many diagnostic technologies but difficult to maintain in tropical climates.

Because new viruses may arise anywhere at any time, researchers have long sought a diagnostic platform that can be deployed worldwide, used with little training, that would communicate data in real time. Gazelle allows for low-cost testing suitable for use in local health clinics, small labs, doctors offices, field hospitals, and emergency situations.

When it comes to viruses, our world knows no boundaries, said Patti White, CEO, Hemex Health. Health care workers and global health experts urgently want an affordable, easy to operate diagnostic platform that connects even the most remote village with public health so that new outbreaks can be identified quickly.

The Gazelle platform combines artificial intelligence, cloud-based data reporting, and miniaturized proven diagnostic technologies that will revolutionize diagnostics the way smart phones changed communications, said White.

We need COVID-19 diagnostics like Gazelle that can be used broadly in under resourced countries, to eliminate transmission there and to remove the constant threat of re-introduction elsewhere, said David Bell, PhD, former World Health Organization scientist who developed and tested diagnostics implementation and training guidance used internationally by Ministries of Health around the world. The Gazelle platform provides integration of rapid, low cost testing with connectivity and digital integration fundamental to future surveillance programs around the world.

While Hemex Health engineered the intelligent reader and cartridge, Seattle-based PAI Life Sciences is developing the biochemical assay required to accurately detect a protein on the surface of COVID-19. PAI has identified an antigen-based mechanism that recognizes the shed protein of the COVID virus.

We are using a highly specific technology to recognize shed proteins from the virus that causes COVID-19. said Darrick Carter, PhD, President and CEO, PAI Life Sciences and Affiliate Professor, Global Health, University of Washington. This unique approach should be more sensitive than antibody-based tests so it can identify even trace viral presence.

PAI Life Sciences developed the first point of care diagnostic screening tool for leprosy and is collaborating on an innovative vaccine for COVID-19 to begin human clinical trials soon.

About Hemex Health

Hemex Health develops and commercializes diagnostic technologies that help make affordable life-sustaining medical care possible for people everywhere. Hemex products are designed to be easy to use and to provide benefit quickly and effectively for the healthcare worker and patient at the point-of-need. The company targets global locations with elimination goals for some of the worlds most deadly diseases, including COVID-19,malaria and large populations at risk for sickle cell disease. The Gazelle technology was developed in collaboration with Case Western Reserve University. Hemex Health is headquartered at the OTRADI Bioscience Incubator located in Portland, Oregon. More information can be found by going to http://www.hemexhealth.com.

Story continues

About PAI Life Sciences

PAI Life Sciences is a biotechnology company located in Seattle, WA, specialized in the developmental and translational research necessary to bring products from the laboratory to bedside. The company focuses on antigens for diagnostics and vaccines. It has developed novel protein biotherapeutics and has a pipeline of products ranging from infectious disease vaccines and adjuvants to therapeutics for cancer.

Contact: David Sheondsheon@whitecoatstrategies.com202 422-6999

Original post:
PAI Life Sciences Biochemistry Expertise Links with Hemex Healths Gazelle Miniaturized Rapid Diagnostic Platform to Develop Pandemic Test - Yahoo...

Biochemistry student creates and motivates – Famuan

Sherlanda Telusmond is a scientist with an artistic soul. Photo courtesy Telusmond

When Sherlanda Telusmond isnt studying the scientific chemistry of living systems, shes doing hair in her bedroom, completing creative commissions, and hosting painting events for young women in her community.

Telusmond, known by her friends and customers as Dada, is a junior biochemistry student and entrepreneur at Florida A&M University. Currently creating acrylic paintings, clothing customizations and tattoo designs (among other things), she is nothing short of a jack-of-all-trades.

Telusmond was born on Dec. 21, 1999 in Fort Lauderdale. As a child, she often found herself drawn to the arts and everything right-brained, despite having dreams of being a doctor when she got older.

It was evident from a young age that she would be a multifaceted individual due to her love of the pursuit of knowledge.

I was a curious child when I was growing up, Telusmond said. My nose was always stuffed in a book and having the opportunity to read as much as I did really piqued my determination to discover more.

Although Telusmond always knew that attending college would come up somewhere along her life path, she wasnt sure what to expect from the experience.

Being a first generation college student that grew up in a traditionally Haitian household did not set detailed expectations for college for me, Telusmond said. All I knew was that I couldnt fail and I had to graduate on time.

Upon her arrival at FAMU, Telusmond quickly realized the importance of the connections that she could make at the university.

I befriended some amazing and talented people on The Hill, Telusmond said. Seeing how diverse the school is along with the large pool of talent that encompasses it definitely acts as a fuel of inspiration to be great.

On Feb. 8, Telusmond hosted her first Paint and Sip event at her house. Providing paint, canvases, brushes and inspiration, Telusmond brought together a group of young women to relax and create.

This was the first of many art-based events that Telusmond plans to hold for the young people in her community.

Chardine Thervil, a rising junior bio/pre-med student at FAMU who attended Telusmonds event, felt that the occasion was a great opportunity for the attendees to explore their artistic sides.

Sherlanda pulled the artist out of everyone that night, Thervil said. People that I didnt even know could paint were giving me Picasso.

Some attendees saw the event as much more than just an arts and crafts night. It was a chance for self expression.

Zharia White, a third year pre-nursing student at FAMU, felt that the event was a comfortable way for her to interact with and meet new people.

Walking into Sherlandas Paint and Sip party felt like hanging out with a crew you never knew you needed, White said. Im usually very shy but I quickly found things in common with the other girls and having an intimate group of people made it easier to be outgoing.

Although Telusmond finds joy in inspiring others to create, her main source of motivation comes from her personal beliefs.

God definitely has a plan for me, Telusmond said. It pushes me to never give up and to keep going because I know something great is coming later.

Telusmonds work can be viewed on her Instagram pages @HairByDadaaa and @Concepts2Canvases.

Read more from the original source:
Biochemistry student creates and motivates - Famuan